$COYA News related to the FDA and CTA is highly likely to drive up the stock price.

$NXL NXL's device has received FDA approval for the treatment of anxiety, depression, and insomnia, and plans to expand its application to Alzheimer's disease and dementia; recent clinical progress may boost the stock price.

$OPTX Winning a new ballistic optics contract with the US military and joining industry leaders in providing AI-driven augmented reality (AR) systems. The January 20th AGM will discuss the 2026 strategy, which could potentially boost the stock price.

$RNAZ Target Price: $10.00 TX-MC138 effectively targets glioblastoma, supporting its future clinical development. With the increasing popularity of nucleoside (nucleotide) analog (NA) therapies, the inhibitory effect of RNAZ on miR-10b is expected to attract widespread attention.

$IBIO Target Price: $2.90 The potential of the IBIO-610 antibody, which promises to bring innovation to the fields of obesity and cardiovascular metabolic diseases, has attracted numerous investors to this rating report, highlighting the uniqueness of its product pipeline.

$OSTX Target Price: $2.00 Regulatory filings and JPMorgan data will drive the stock price up.

$LAB Target Price: $1.90 A life science tools company that provides genomics and proteomics tools, including flow cytometry and mass cytometer systems, for biological research and diagnostics.

$PMCB Target Price: $1.10 CEO acquires $128k stock, Jonathan Schechter buys $48.2k. The cell therapy market is growing, and PMCB's Cell-in-a-Box has great potential.

$HOOD I miss the days when you open up your Robinhood app and you see that oh so sweet 5.00% APY on your cash. Now it’s only 3.75%… 😭 A 5% whole number just…just… looks cooler. Raise em rates Jay Pow Wow lol

$RMSG A real estate technology platform that connects industry participants through social features.

$MBIO FDA meeting and data updates could drive a rebound.

$NVDA 10 years ago: • $1/share • 10x earnings $NVDA today: • $185/share • 26x earnings That means the stock is up ~18,400% while valuation multiple has barely more than doubled. That’s what happens when you own the infrastructure every new digital economy has to run on.

A portfolio involving these 10 picks will dominate & outperform the markets by a far margin in 2026… 1. $ONDS ~ Provides the secure & jam-resistant communication for autonomous drone operations. 2. $ASTS ~ Building the communication layer for space based connectivity. 3. $ZETA

$BABA is going to see its largest breakout in its history over the next couple months… With a massive revenue and stock price disconnect $BABA will catch back up soon. The last time I called for a move like this $BABA ran from $90 to $180+ Save this post to look back on…

$TSLA has brought the largest lithium refinery in the U.S. online

$IXHL Forecasted increase: 18%-30% IHL-42X receives FDA Fast Track approval, accelerating the approval process.

$RIOT bought 200 acres in Rockdale for $96M using proceeds from ~1,080 $BTC sold and signed a 25MW data center lease with $AMD. The 10-year deal is valued at ~$311M with extensions up to ~$1B plus options for AMD to add 75MW and a right of first refusal on another 100MW.

$SPX seasonality suggests February is the second weakest month of the year. I’m just the messenger.

10 STOCKS UNDER $2B MARKET CAP WORTH TRACKING 1. $CLPT | ClearPoint Neuro 2. $AEHR | Aehr Test System 3. $JMIA | Jumia 4. $OSS | One Stop Systems 5. $PRCT | PROCEPT BioRobotics 6. $PGY | Pagaya 7. $PRME | Prime Medicine 8. $KRKNF | Kraken Robotics 9. $RR | Richtech Robotics